Skip to main content
OpenTrials
Completed

NCT Number: NCT02820415

PGS on Blastocysts From Vitrified and Fresh Oocytes

Oocyte accumulation by vitrification is a valid strategy to increase the number of available embryos for biopsy and the number of viable euploid embryos to transfer after preimplantation genetic testing.

Completed

Looking for future studies?

Notify Me

Key information

Age range

28 year–43 year

Sex eligibility

Female

Study type

Observational

Primary location

Sandrine Chamayou

Sant'Agata Li Battiati, 95030, Italy

About this study

In the present study, the investigators considered the hypothesis to accumulate vitrified oocytes with a view to increasing the number of oocytes for micro-injection and consequently the number of blastocyst to diagnose for patients with normal ovarian reserve and candidate for PGT. The partecipants were proposed to undergo several cycles of ovarian stimulation. In the first cycles, mature (metaphase II) oocytes were vitrified and consequently accumulated. In the last cycle, the freshly produced mature oocytes and the previously accumulated ones were micro-injected together with the same partner's semen sample. PGT was performed on blastocysts produced from the two sources of oocytes. The comprehensive chromosomal analysis of biopsied trophectoderm cells was performed using NGS technology. The number of available euploid blastocyst and the proportion of euploid/aneuploidy embryos from fresh and vitrified/warmed oocytes were compared. In conclusion the investigators evaluated the efficacy of oocyte accumulation by vitrification in increasing the number of available embryos for biopsy and the number of viable euploid embryos to transfer after PGT.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • infertile women
  • normal ovarian reserve
  • with repeated implantation failure or reccurent miscarriage
  • undergoing ICSI and asking to know the state of health of the embryos prior to embryo transfer

Treatment and study plan

chromosomal status of blastocysts from fresh and vitrified/warmed oocytes

Other

Primary outcomes

  1. rate of euploidy in blastocyst from fresh and vitrified/warmed oocytes

    Time frame: 1 year

    from fresh and vitrified/warmed oocytes

Sponsors and collaborators

Lead sponsor

Unità di Medicina della Riproduzione, Italy

Other

Registry information

Official study title

Oocyte Accumulation by Vitrification is a Valid Strategy to Increase the Number of Euploid Available Embryos for Biopsy and Transfer After Preimplantation Genetic Testing

Acronym: PGSvitfreov

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Jul 1, 2016
Registry last updated
Jul 1, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.